Preterm birth and random plasma insulin levels at birth and in early childhood

Guoying Wang1, Sara Divall2, Sally Radovick2

  • 1Department of Population, Family and Reproductive Health, Center on Early Life Origins of Disease, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland.

JAMA
|February 13, 2014
PubMed

Insights

Preterm birth is linked to higher insulin levels at birth and in early childhood, suggesting potential long-term metabolic health risks. This association between lower gestational age and elevated insulin warrants further investigation for implications in insulin resistance and type 2 diabetes development.

Area of Science:

  • Endocrinology
  • Neonatal Health
  • Metabolic Disorders

Background:

  • Previous research indicates a link between preterm birth and insulin resistance in later life.
  • However, whether altered insulin homeostasis is detectable at birth and persists through childhood remains unclear.

Purpose of the Study:

  • To determine if preterm birth is associated with elevated plasma insulin levels at birth.
  • To investigate if this association persists into early childhood.

Main Methods:

  • A prospective birth cohort study included 1358 children.
  • Plasma insulin levels were measured at birth (cord blood) and in early childhood (median age 1.4 years).
  • Participants were categorized into four gestational age groups: full term (≥39 wk), early term (37-38 wk), late preterm (34-36 wk), and early preterm (<34 wk).

Main Results:

  • Higher insulin levels were observed at birth and in early childhood with decreasing gestational age.
  • Specifically, early preterm infants (<34 wk) had significantly higher insulin levels at birth (2.05-fold) and in early childhood (1.31-fold) compared to full-term infants.
  • The association was attenuated after adjusting for postnatal weight gain and was not significant after adjusting for birth insulin levels. Infants in the top insulin tertile at birth were more likely to remain in the top tertile in childhood.

Conclusions:

  • An inverse association exists between gestational age and elevated plasma insulin levels at birth and in early childhood.
  • These findings suggest that preterm birth may be a risk factor for altered insulin homeostasis from birth.
  • Further research is needed to explore the implications for future insulin resistance and type 2 diabetes development.
Abstract

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.9K
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
45
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and...
24
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
17
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.3K